|
Variables
|
% AHI <15/h
|
% AHI ≥15/h
|
OR (IC 95%)
|
P-value
|
|---|
|
Gender
| | | |
<0.001
|
|
Male
|
77.02%
|
22.98%
|
7.73 (4.92 to 12.15)
| |
|
Female
|
96.28%
|
3.72%
|
1
|
|
Snoring
| | | |
<0.001
|
|
Yes
|
77.59%
|
22.41%
|
5.36 (3.61 to 7.96)
|
|
No
|
94.89%
|
5.11%
|
1
|
|
Epworth
| | | |
<0.001
|
|
≤ 10
|
89.20%
|
10.80%
|
1
|
|
>10
|
82.44%
|
17.56%
|
1.76 (1.28 to 2.41)
|
|
BDI
| | | |
0.002
|
|
≤ 8
|
83.78%
|
16.22%
|
3.21 (1.60 to 6.44)
|
|
>8 & <16
|
88.07%
|
11.93%
|
2.24 (1.06 to 4.75)
|
|
≥16
|
94.30%
|
5.70%
|
1
|
|
ISI
| | | |
0.004
|
|
< 15
|
80.90%
|
19.10%
|
2.22 (1.34 to 3.68)
|
|
≥15 & <21
|
85.16%
|
14.84%
|
1.64 (1.10 to 2.43)
|
|
≥21
|
90.39%
|
9.61%
|
1
|
|
Metabolic syndrome
| | | |
<0.001
|
|
Yes
|
60.71%
|
39.29%
|
4.97 (3.27 to 7.56)
|
|
No
|
88.49%
|
11.51%
|
1
|
|
Benzodiazepines use
| | | |
0.394
|
|
Yes
|
87.88%
|
12.12%
|
0.83 (0.54 to 1.28)
|
|
No
|
85.74%
|
14.26%
|
1
|
|
Z-drugs use
| | | |
0.231
|
|
Yes
|
90.10%
|
9.90%
|
0.66 (0.34 to 1.30)
|
|
No
|
85.79%
|
14.21%
|
1
|
|
Antidepressant therapy
| | | |
0.137
|
|
Yes
|
88.30%
|
11.70%
|
0.76 (0.53 to 1.09)
|
|
No
|
85.19%
|
14.81%
|
1
|
|
Smoking
| | | |
0.944
|
|
Yes
|
86.24%
|
13.76%
|
0.99 (0.68 to 1.43)
|
|
No
|
86.08%
|
13.92%
|
1
|
|
Alcohol
| | | |
<0.001
|
|
Yes
|
79.73%
|
20.27%
|
1.87 (1.33 to 2.62)
|
|
No
|
88.02%
|
11.98%
|
1
|
|
Insomnia maintenance
| | | |
0.035
|
|
Yes
|
87.77%
|
12.23%
|
1
|
|
No
|
83.65%
|
16.35%
|
1.40 (1.02 to 1.92)
|
|
BMI (kg/m2)
| | | |
<0.001
|
|
< 25
|
97.19%
|
2.81%
|
1
|
|
≥ 25 & <30
|
83.94%
|
16.06%
|
6.62 (3.77 to 11.62)
|
|
≥30
|
69.70%
|
30.30%
|
15.05 (8.69 to 26.08)
|
|
Age (years)
| | | |
<0.001
|
|
< 50
|
91.27%
|
8.73%
|
1
|
|
≥ 50 & <65
|
78.99%
|
21.01%
|
2.78 (1.98 to 3.92)
|
|
≥ 65
|
57.81%
|
42.19%
|
7.63 (4.41 to 13.22)
|
|
CRP (mg/L)
| | | |
0.002
|
|
≤7
|
86.92%
|
13.08%
|
1
|
|
>7
|
75.00%
|
25.00%
|
2.21 (1.33 to 3.69)
|
-
BMI Body Mass Index, BDI Beck Depression Inventory, AHI Apnea-Hypopnea Index, ISI Insomnia Severity Index
